Cholesterol oxidation products and disease: An emerging topic of interest in medicinal chemistry

Current Medicinal Chemistry

Volumn 16, Issue 6, 2009, Pages 685-705

  Sottero, Barbara ^a   Gamba, Paola ^a   Gargiulo, Simona ^a   Leonarduzzi, Gabriella ^a   Poli, Giuseppe ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Antioxidants; Apoptosis; Cholesterol; Inflammation; Lipid metabolism; Oxysterols; Statins

Indexed keywords

ALPHA TOCOPHEROL; ANTIESTROGEN; ANTIOXIDANT; APIGENIN; ASCORBIC ACID; ASTAXANTHIN; ATORVASTATIN; CELL ADHESION MOLECULE; CHOLESTEROL DERIVATIVE; EBSELEN; FENOFIBRATE; FLUINDOSTATIN; GLABRIDIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KAEMPFEROL; LYCOPENE; MEVINOLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYPHENOL DERIVATIVE; PRAVASTATIN; PROBUCOL; QUERCETIN; ROSMARINUS OFFICINALIS EXTRACT; RUTOSIDE; SALVIA MILTIORRHIZA EXTRACT; SIMVASTATIN; SODIUM SELENITE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BINDING SITE; CALCIUM TRANSPORT; CARDIOVASCULAR RISK; CELL MEMBRANE PERMEABILITY; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CHRONIC DISEASE; CLINICAL TRIAL; CYTOKINE RELEASE; CYTOSKELETON; CYTOTOXICITY; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESEARCH; ENZYME ACTIVITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPID BILAYER; LIPID METABOLISM; LIPID OXIDATION; LIPID RAFT; LIPOPROTEIN METABOLISM; MEMBRANE STRUCTURE; METABOLITE; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REVIEW; STEROIDOGENESIS; STEROL ANALYSIS; STRUCTURE ANALYSIS; TREATMENT DURATION;

ALZHEIMER DISEASE; ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; FIBROSIS; HUMANS; INFLAMMATION; OXIDATION-REDUCTION;

EID: 65649083410     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709787458353     Document Type: Review

References (220)

1. Steinberg, D. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat. Med., 2002, 8, 1211-7.
2. Libby, P. Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr. Rev., 2007, 65, S140-6.
3. Lucas, S.M.; Rothwell, N.J.; Gibson, R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol., 2006, 147, S232-40.
4. Poli, G.; Leonarduzzi, G.; Biasi, F.; Chiarpotto, E. Oxidative stress and cell signalling. Curr. Med. Chem., 2004, 11, 1163-82.
5. Leonarduzzi, G.; Chiarpotto, E.; Biasi, F.; Poli, G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res., 2005, 49, 1044-9.
6. Van Reyk, D.M.; Brown, A.J.; Hult'en, L.M.; Dean, R.T.; Jessup, W. Oxysterols in biological systems: Sources, metabolism and pathophysiological relevance. Redox Rep., 2006, 11, 255-62.
7. Brown, A.J.; Jessup, W. Oxysterols and atherosclerosis. Atherosclerosis, 1999, 142, 1-28.
8. Guardiola, F.; Dutta, P.C.; Codony, R.; Savaga, G.P. Cholesterol and Phytosterol Oxidation Products: Analysis, Occurence and Biological Effects, AOCS: Champaign, IL, 2002.
9. Smith, L.L.; Johnson, B.H. Biological activities of oxysterols. Free Radic. Biol. Med., 1989, 7, 285-332.
10. Schroepfer, G.J.Jr. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol. Rev., 2000, 80, 361-554.
11. Russell, D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta, 2000, 1529, 126-35.
12. Van Amerongen, A.; Demel, R.A.; Westerman, J.; Wirtz, K.W. Transfer of cholesterol and oxysterol derivatives by the nonspecific lipid transfer protein (sterol carrier protein 2): A study on its mode of action. Biochim. Biophys. Acta, 1989, 1004, 36-43.
13. Kan, C.C.; Yan, J.; Bittman, R. Rates of spontaneous exchange of synthetic radiolabeled sterols between lipid vesicles. Biochemistry, 1992, 31, 1866-74.
14. Sevanian, A.; McLeod, L. Cholesterol autoxidation in phospholipid membrane bilayers. Lipids, 1987, 22, 627-36.
15. Mouritsen, O.G.; Zuckermann, M.J. What's so special about cholesterol? Lipids, 2004, 39, 1101-13.
16. Theunissen, J.J.; Jackson, R.L.; Kempen, H.J.; Demel, R.A. Membrane properties of oxysterols. Interfacial orientation, influence on membrane permeability and redistribution between membranes. Biochim. Biophys. Acta, 1986, 860, 66-74.
17. Kauffman, J.M.; Westerman, P.W.; Carey, M.C. Fluorocholesterols, in contrast to hydroxycholesterols, exhibit interfacial properties similar to cholesterol. J. Lipid Res., 2000, 41, 991-1003.
18. Verhagen, J.C.; ter Braake, P.; Teunissen, J.; van Ginkel, G.; Sevanian, A. Physical effects of biologically formed cholesterol oxidation products on lipid membranes investigated with fluorescence depolarization spectroscopy and electron spin resonance. J. Lipid Res., 1996, 37, 1488-502.
19. Massey, J.B. Membrane and protein interactions of oxysterols. Curr. Opin. Lipidol., 2006, 17, 296-301.
20. Massey, J.B.; Pownall, H.J. Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry, 2006, 45, 10747-58.
21. Massey, J.B.; Pownall, H.J. The polar nature of 7-ketocholesterol determines its location within membrane domains and the kinetics of membrane microsolubilization by apolipoprotein A-I. Biochemistry, 2005, 44, 10423-33.
22. Holmes, R.P.; Yoss, N.L. 25-Hydroxysterols increase the permeability of liposomes to Ca2+ and other cations. Biochim. Biophys. Acta, 1984, 770, 15-21.
23. Boissonneault, G.A.; Hennig, B.; Ouyang, C.-M. Oxysterols, cholesterol biosynthesis, and vascular endothelial cell monolayer, barrier function. Proc. Soc. Exp. Biol. Med., 1991, 196, 338-43.
24. Maxfield, F.R.; Tabas, I. Role of cholesterol and lipid organization in disease. Nature, 2005, 438, 612-21.
25. Tabas, I. Consequences of cellular cholesterol accumulation: Basic concepts and physiological implications. J. Clin. Invest., 2002, 110, 905-11.
26. Chang, T.-Y.; Chang, C.C.; Ohgami, N.; Yamauchi, Y. Cholesterol sensing, trafficking, and esterification. Annu. Rev. Cell Dev. Biol., 2006, 22, 129-57.
27. Gill, S.; Chow, R.; Brown, A.J. Sterol regulators of cholesterol homeostasis and beyond: The oxysterol hypothesis revisited and revised. Progr. Lipid Res., 2008, 47, 391-404.
28. Kandutsch, A.A.; Chen, H.W. Inhibition of sterol synthesis in cultured mouse cells by 7α-hydroxycholesterol, 7β-hydroxycholesterol, and 7-ketocholesterol. J. Biol. Chem., 1973, 248, 8408-17.
29. Tham, P.; Peng, S.-K.; Taylor, C.B.; Mikkelson, B. Suppression of cholesterol synthesis in aortic smooth muscle cell cultures by oxidation derivatives of cholesterol. Fed. Proc., 1978, 37, 1381.
30. Brown, M.S.; Goldstein, J.L. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J. Biol. Chem., 1974, 249, 7306-14.
31. Beg, Z.H.; Renzikov, D.C.; Avigan, J. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: Modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone. Arch. Biochem. Biophys., 1986, 244, 310-22.
32. Taylor, F.R. Correlation among oxysterol potencies in the regulation of the degradation of 3-hydroxy-3-methylglutaryl CoA reductase, the repression of 3-hydroxy-3-methylglutaryl CoA synthase and affinities for the oxysterol receptor. Biochem. Biophys. Res. Commun., 1992, 186, 182-9.
33. Field, F.J.; Shreves, T.; Fujiwara, D.; Murthy, S.; Albright, E.; Mathur, S.N. Regulation of gene expression and synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by micellar cholesterol in CaCo-2 cells. J. Lipid Res., 1991, 32, 1811-21.
34. Brown, M.S.; Dana, S.E.; Goldstein, J.L. Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. J. Biol. Chem., 1975, 250, 4025-7.
35. Bates, S.R.; Jett, C.M.; Miller, J.E. Prevention of the hyperlipidemic serum or LDL-induced cellular cholesterol ester accumulation by 22-hydroxycholesterol and its analogue. Biochim. Biophys. Acta, 1983, 753, 281-93.
36. Zhang, H.F.; Basra, H.J.; Steinbrecher, U.P. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J. Lipid Res., 1990, 31, 1361-9.
37. Kusuhara, H.; Shimada, O.; Inui, J. Effect of 25-hydroxycholesterol on cholesteryl ester formation in Caco-2 cells. Lipids, 1992, 27, 478-80.
38. Bhuvaneswaran, C.; Synouri-Vrettakou, S.; Mitropoulos, K.A. Activation of acyl-CoA: Cholesterol acyltransferase in rat liver microsomes by 25-hydroxycholesterol. Biochem. Pharmacol., 1997, 53, 27-34.
39. Drevon, C.A.; Weinstein, D.B.; Steinberg D. Regulation of cholesterol esterification and biosynthesis in monolayer cultures of normal adult rat hepatocytes. J. Biol. Chem., 1980, 255, 9128-37.
40. Cheng, D.; Chang, C.C.; Qu, X.; Chang, T.Y. Activation of acylcoenzyme A:cHolesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem., 1995, 270, 685-95.
41. Chang, T.Y.; Chang, C.C.; Cheng, D. Acyl-coenzyme A:cHolesterol acyltransferase. Annu. Rev. Biochem., 1997, 66, 613-38.
42. Lange, Y.; Steck, T.L. Quantitation of the pool of cholesterol associated with acyl-CoA:cHolesterol acyltransferase in human fibroblasts. J. Biol. Chem., 1997, 272, 13103-8.
43. Jepson, C.A.; Harrison, J.A.; Kraemer, F.B.; Yeaman, S.J. Down-regulation of hormone-sensitive lipase in sterol ester-laden J774.2 macrophages. Biochem. J., 1996, 318, 173-7.
44. Schwartz, M.A.; Margolis, S. Effects of drugs and sterols on cholesterol 7α-hydroxylase activity in rat liver microsomes. J. Lipid Res., 1983, 24, 28-33.
45. Breuer, O.; Sudjana-Sugiaman, E.; Eggertsen, G.; Chiang, J.Y.; Björkhem, I. Cholesterol 7 α-hydroxylase is up-regulated by the competitive inhibitor 7-oxocholesterol in rat liver. Eur. J. Biochem., 1993, 215, 705-10.
46. Agassandian, M.; Zhou, J.; Tephly, L.A.; Ryan, A.J.; Carter, A.B.; Mallampalli, R.K. Oxysterols inhibit phosphatidylcholine synthesis via ERK docking and phosphorylation of CTP:pHosphocholine cytidylyltransferase. J. Biol. Chem., 2005, 280, 21577-87.
47. Maor, I., Mandel, H., Aviram, M. Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes. A possible role for 7-ketocholesterol. Arterioscler. Thromb. Vasc. Biol., 1995, 15, 1378-87.
48. Osada, K.; Kodama, T.; Noda, S.; Yamada, K.; Sugano, M. Oxidized cholesterol modulates age-related change in lipid metabolism in rats. Lipids, 1995, 30, 405-13.
49. Osada, K.; Kodama, T.; Yamada, K.; Sugano, M. Dietary oxidized cholesterol modulates cholesterol metabolism and linoleic acid desaturation in rats fed high-cholesterol diets. Lipids, 1998, 33, 757-64.
50. Antonio, V.; Janvier, B.; Brouillet, A.; Andreani, M.; Raymondjean, M. Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. Biochem. J., 2003, 376, 351-60.
51. Cader, A.A.; Steinberg, F.M.; Mazzone, T.; Chait, A. Mechanisms of enhanced macrophage apoE secretion by oxidized LDL. J. Lipid Res., 1997, 38, 981-91.
52. Laffitte, B.A.; Repa, J.J.; Joseph, S.B.; Wilpitz, D.C.; Kast, H.R.; Mangelsdorf, D.J.; Tontonoz, P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Nat. Acad. Sci. USA, 2001, 98, 507-12.
53. Abildayeva, K.; Jansen, P.J.; Hirsch-Reinshagen, V.; Bloks, V.W.; Bakker, A.H.; Ramaekers, F.C.; de Vente, J.; Groen, A.K.; Wellington, C.L.; Kuipers, F.; Mulder, M. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. J. Biol. Chem., 2006, 281, 12799-808.
54. Hultén, L.M.; Lindmark, H.; Diczfalusy, U.; Björkhem, I.; Ottosson, M.; Liu, Y.; Bondjers, G.; Wiklund, O. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J. Clin. Invest., 1996, 97, 461-8.
55. Peng. S.K.; Zhang, X.; Chai, N.N.; Wan, Y.; Morin, R.J. Inhibitory effect of cholesterol oxides on low density lipoprotein receptor gene expression. Artery, 1996, 22, 61-79.
56. Leonarduzzi, G.; Gamba, P.; Gargiulo, S.; Sottero, B.; Kadl, A.; Biasi, F.; Chiarpotto, E.; Leitinger, N.; Vendemmiale, G.; Serviddio, G.; Poli, G. Oxidation as a crucial reaction for cholesterol to induce tissue degeneration: CD36 overexpression in human promonocytic cells treated with a biologically relevant oxysterol mixture. Aging Cell, 2008, 7, 375-82.
57. Baldan, A.; Tarr, P.; Lee, R.; Edwards, P.A. ATP-binding cassette transporter G1 and lipid homeostasis. Curr. Opin. Lipidol., 2006, 17, 227-32.
58. Hirayama, T.; Honda, A.; Matsuzaki, Y.; Miyazaki, T.; Ikegami, T.; Doy, M.; Xu, G.; Lea, M.; Salen, G. Hypercholesterolemia in rats with hepatomas: Increased oxysterols accelerate efflux but do not inhibit biosynthesis of cholesterol. Hepatology, 2006, 44, 602-11.
59. Brown, J. 3rd; Theisler, C.; Silberman, S.; Magnuson, D.; Gottardi-Littell, N.; Lee, J.M.; Yager, D.; Crowley, J.; Sambamurti, K.; Rahman, M.M.; Reiss, A.B.; Eckman, C.B.; Wolozin, B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem., 2004, 279, 34674-81.
60. Venkateswaran, A.; Laffitte, B.A.; Joseph, S.B.; Mak, P.A.; Wilpitz, D.C.; Edwards, P.A.; Tontonoz, P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRα. Proc. Nat. Acad. Sci. USA, 2000, 97, 12097-102.
61. Li, T.; Chen, W.; Chiang, J.Y. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J. Lipid Res., 2007, 48, 373-84.
62. Fujiyoshi, M.; Ohtsuki, S.; Hori, S.; Tachikawa, M.; Terasaki, T. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. J. Neurochem., 2007, 100, 968-78.
63. Fukumoto, H.; Deng, A.; Irizarry, M.C.; Fitzgerald, M.L.; Rebeck, G.W. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels. J. Biol. Chem., 2002, 277, 48508-13.
64. Brown, M.S.; Goldstein, J.L. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell, 1997, 89, 331-40.
65. Horton, J.D.; Shah, N.A.; Warrington, J.A.; Anderson, N.N.; Park, S.W.; Brown, M.S.; Goldstein, J.L. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc. Nat. Acad. Sci. USA, 2003, 100, 12027-32.
66. Radhakrishnan, A.; Ikeda, Y.; Kwon, H.J.; Brown, M.S.; Goldstein, J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Oxysterols block transport by binding to Insig. Proc. Nat. Acad. Sci. USA, 2007, 104, 6511-8.
67. Sun, L.-P.; Seemann, J.; Goldstein, J.L.; Brown M.S. Sterolregulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Nat. Acad. Sci. USA, 2007, 104, 6519-26.
68. Sever, N.; Yang, T.; Brown, M.S.; Goldstein, J.L.; DeBose-Boyd, R.A. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. Mol. Cell, 2003, 11, 25-33.
69. Zelcer, N.; Tontonoz, P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest., 2006, 116, 607-14.
70. Valledor, A.F.; Ricote, M. Nuclear receptor signaling in macrophages. Biochem. Pharmacol., 2004, 67, 201-12.
71. Lehmann, J.M.; Kliewer, S.A.; Moore, L.B.; Smith-Oliver, T.A.; Oliver, B.B.; Su, J.-L.; Sundseth, S.S.; Winegar, D.A.; Blanchard, D.E.; Spencer, T.A.; Willson, T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem., 1997, 272, 3137-40.
72. Fu, X.; Menke, J.G.; Chen, Y.; Zhou, G.; MacNaul, K.L.; Wright, S.D.; Sparrow, C.P.; Lund, E.G. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J. Biol. Chem., 2001, 276, 38378-87.
73. Janowski, B.A.; Grogan, M.J.; Jones, S.A.; Wisely, G.B.; Kliewer, S.A.; Corey, E.J.; Mangelsdorf, D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRα and LXRAb. Proc. Nat. Acad. Sci. USA, 1999, 96, 266-71.
74. Svensson, S.; Ostberg, T.; Jacobsson, M.; Norström, C.; Stefansson, K.; Hallén, D.; Johansson, I.C.; Zachrisson, K.; Ogg, D.; Jendeberg, L. Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand-binding domains in a fully agonistic conformation. EMBO J., 2003, 22, 4625-33.
75. Björkhem, I.; Meaney, S.; Diczfalusy, U. Oxysterols in human circulation: Which role do they have? Curr. Opin. Lipidol., 2002, 13, 247-53.
76. Kandutsch, A.A.; Chen, H.W.; Shown, E.P. Binding of 25-hydroxycholesterol and cholesterol to different cytoplasmic proteins. Proc. Nat. Acad. Sci. USA, 1977, 74, 2500-3.
77. Taylor, F.R.; Saucier, S.E.; Shown, E.P.; Parish, E.J.; Kandutsch, A.A. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J. Biol. Chem., 1984, 259, 12382-7.
78. Ridgway, N.D.; Dawson, P.A.; Ho, Y.K.; Brown, M.S.; Goldstein, J.L. Translocation of oxysterol binding protein to Golgi apparatus triggered by ligand binding. J. Cell Biol., 1992, 116, 307-19.
79. Olkkonen, V.M.; Johansson, M.; Suchanek, M.; Yan, D.; Hynynen, R.; Ehnholm, C.; Jauhiainen, M.; Thiele, C.; Lehto, M. The OSBP-related proteins (ORPs): Global sterol sensors for co-ordination of cellular lipid metabolism, membrane trafficking and signalling processes? Biochem. Soc. Trans., 2006, 34, 389-91.
80. Fairn, G.D.; McMaster, C.R. Emerging roles of the oxysterol-binding protein family in metabolism, transport, and signaling. Cell. Mol. Life Sci., 2008, 65, 228-36.
81. Wang, P-Y.; Weng, J.; Anderson, R.G. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science, 2005, 307, 1472-6.
82. Wang, P.-Y.; Weng, J.; Lee S.; Anderson, R.G. The N terminus controls sterol binding while the C terminus regulates the scaffolding function of OSBP. J. Biol. Chem., 2008, 283, 8034-45.
83. Perry, R.J.; Ridgway, N.D. Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol. Biol. Cell, 2006, 17, 2604-16.
84. Kandutsch, A.A.; Thompson, E.B. Cytosolic proteins that bind oxygenated sterols. Cellular distribution, specificity, and some properties. J. Biol. Chem., 1980, 255, 10813-21.
85. Im, Y.J.; Raychaudhuri, S.; Prinz, W.A.; Hurley, J.H. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature, 2005, 437, 154-8.
86. Monier, S.; Samadi, M.; Prunet, C.; Denance, M.; Laubriet, A.; Athias, A.; Berthier, A.; Steinmetz, E.; Jurgens, G.; NègreSalvayre, A.; Bessède, G.; Lemaire-Ewing, S.; Neel, D.; Gambert, P.; Lizard, G. Impairment of the cytotoxic and oxidative activities of 7β-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. Biochem. Biophys. Res. Commun., 2003, 303, 814-24.
87. Zhang, Y.; Yu, C.; Liu, J.; Spencer, T.A.; Chang, C.C.; Chang, TY. Cholesterol is superior to 7-ketocholesterol or 7α-hydroxycholesterol as an allosteric activator for acyl-coenzyme A: Cholesterol acyltransferase 1. J. Biol. Chem. 2003, 278, 11642-7.
88. Szedlacsek, S.E.; Wasowicz, E.; Hulea, S.A.; Nishida, H.I.; Kummerow, F.A.; Nishida, T. Esterification of oxysterols by human plasma lecithin-cholesterol acyltransferase. J. Biol. Chem., 1995, 270, 11812-9.
89. Li-Hawkins, J.; Lund, E.G.; Turley, S.D.; Russell, D.W. Disruption of the oxysterol 7α-hydroxylase gene in mice. J. Biol. Chem., 2000, 275, 16536-42.
90. Norlin, M.; Andersson, U.; Björkhem, I; Wikvall, K. Oxysterol 7αhydroxylase activity by cholesterol 7α-hydroxylase (CYP7A). J. Biol. Chem., 2000, 275, 34046-53.
91. Li-Hawkins, J.; Lund, E.G.; Bronson, A.D; Russell, D.W. Expression cloning of an oxysterol 7α-hydroxylase selective for 24hydroxycholesterol. J. Biol. Chem., 2000, 275, 16543-9.
92. Norlin M.; Toll, A.; Bjorkhem, I.; Wikvall, K. 24-Hydroxycholesterol is a substrate for hepatic cholesterol 7α-hydroxylase (CYP7A). J. Lipid Res., 2000, 41, 1629-39.
93. Lyons, M.A.; Brown, A.J. Metabolism of an oxysterol, 7ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. Lipids, 2001, 36, 701-11.
94. Norlin, M.; von Bahr, S.; Björkhem, I.; Wikvall, K. On the substrate specificity of human CYP27A1: Implications for bile acid and cholestanol formation. J. Lipid Res., 2003, 44, 1515-22.
95. Chen, Z.-H.; Yoshida, Y.; Saito, Y.; Noguchi, N.; Niki, E. Adaptive response induced by lipid peroxidation products in cell cultures. FEBS Lett., 2006, 580, 479-83.
96. Chen, Z.-H.; Yoshida, Y.; Saito, Y.; Sekine, A.; Noguchi, N.; Niki, E. Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-δ(12,14)prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms. J. Biol. Chem., 2006, 281, 14440-5.
97. Panini, S.R.; Sinensky, M.S. Mechanisms of oxysterol-induced apoptosis. Curr. Opin. Lipidol., 2001, 12, 529-33.
98. Leonarduzzi, G.; Poli, G.; Sottero, B.; Biasi, F. Activation of the mitochondrial pathway of apoptosis by oxysterols. Front. Biosci., 2007, 12, 791-9.
99. Rho, M.-C.; Kim, Y.K.; Chang, J.S.; Lee, H.S.; Baek, J.A.; Chung, M.Y.; Lee, H.C.; Lee, H.W.; Rhim, B.Y.; Reidy, M.A.; Kim, K. 7Ketocholesterol predisposes human aorta smooth muscle cells to Fas-mediated death. J. Mol. Cell Cardiol., 2005, 39, 823-32.
100. Lee, H.S.; Chang, J.S.; Baek, J.A.; Chung, M.Y.; Lee, H.C.; Rhim, B.Y.; Sok, D.E.; Rho, M-C.; Kim, Y.K.; Kim, K. TNF-α activates death pathway in human aorta smooth muscle cell in the presence of 7-ketocholesterol. Biochemic. Biophys. Res. Commun., 2005, 333, 1093-9.
101. Neekhra, A.; Luthra, S.; Chwa, M.; Seigel, G.; Gramajo, A.L.; Kuppermann, B.D.; Kenney, M.C. Caspase-8, -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells. Invest. Ophtalmol. Vis. Sci., 2007, 48, 1362-7.
102. Luthra, S.; Fardin, B.; Dong, J.; Hertzog, D.; Kamjoo, S.; Gebremariam, S.; Butani, V.; Narayanan, R.; Mungcal, J.K.; Kuppermann, B.D.; Kenney, M.C. Activation of caspase-8 and caspase-12 pathways by 7-ketocholesterol in human retinal pigment epithelial cells. Invest. Ophtalmol. Vis. Sci., 2006, 47, 5569-75.
103. Miguet, C.; Monier, S.; Bettaieb, A.; Athias, A.; Bessæde, G.; Laubriet, A.; Lemaire, S.; Néel, D.; Gambert, P.; Lizard, G. Ceramide generation occurring during 7β-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ., 2001, 8, 83-99.
104. Liu, H.; Yuan, L.; Xu, S.; Wang, K.; Zhang, T. Cholestane3β, 5α,6β-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells. J. Cell Biochem., 2005, 96, 198-208.
105. Ares, M.P.; Pörn-Ares, M.I.; Moses, S.; Thyberg, J.; JunttiBerggren, L.P.; Berggren, P.; Hultgårdh-Nilsson A.; Kallin, B.; Nilsson, J. 7β-hydroxycholesterol induces Ca(2+) oscillations, MAP kinase activation and apoptosis in human aortic smooth muscle cells. Atherosclerosis, 2000, 153, 23-35.
106. Panini S.R., Yang L., Rusinol A.E., Sinensky M.S., Bonventre J.V., Leslie C.C. Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL/oxysterol. J. Lipid Res., 2001, 42, 1678-86.
107. Biasi, F.; Leonarduzzi, G.; Vizio, B.; Zanetti, D.; Sevanian, A.; Sottero, B.; Verde, V.; Zingaro, B.; Chiarpotto, E.; Poli, G. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: Implications for proatherogenic gene modulation. FASEB J., 2004, 18, 693-5.
108. Kölsch, H.; Ludwig, M.; Lütjohann, D.; Rao, M.L. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol17β. J. Neural. Transm., 2001, 108, 475-88.
109. O'Callaghan, Y.C.; Woods, J.A.; O'Brien, N.M. Characteristics of 7β-hydroxycholesterol-induced cell death in a human monocytic blood cell line, U937, and a human hepatoma cell line, HepG2. Toxicol. In vitro, 2002, 16, 245-51.
110. Lizard, G.; Gueldry, S.; Sordet, O.; Monier, S.; Athias, A.; Miguet, C.; Bessede, G.; Lemaire, S.; Solary, E.; Gambert, P. Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J., 1998, 12, 1651-63.
111. Leonarduzzi G.; Vizio, B.; Sottero, B.; Verde, V.; Gamba, P.; Mascia, C.; Chiarpotto, E.; Poli, G.; Biasi, F. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid. Redox Signal., 2006, 8, 375-80.
112. Pedruzzi, E.; Guichard, C.; Ollivier, V.; Driss, F.; Fay, M.; Prunet, C.; Marie, J.-C.; Pouzet, C.; Samadi, M.; Elbim, C.; O'dowd, Y.; Bens, M.; Vandewalle, A.; Gougerot-Pocidalo, M.A.; Lizard, G.; Ogier-Denis, E. NAD(P)H oxidase Nox-4 mediates 7ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol., 2004, 24, 10703-17.
113. Palozza, P.; Serini, S.; Verdecchia, S.; Ameruso, M.; Trombino, S.; Picci, N.; Moneto, G.; Ranelletti, F.O. Redox regulation of 7ketocholesterol-induced apoptosis by β-carotene in human macrophages. Free Radic. Biol. Med., 2007, 42, 1579-90.
114. Rosenblat, M.; Aviram, M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse: Inhibitory role for vitamin E. Atherosclerosis, 2002, 160, 69-80.
115. Clare, K., Hardwick, S.J., Carpenter, K.L., Weeratunge, N., Mitchinson, M.J. Toxicity of oxysterols to human monocytemacrophages. Atherosclerosis, 1995, 118, 67-75.
116. Berthier, A.; Lemaire-Ewing, S.; Prunet, C.; Monier, S.; Athias, A.; Bessède, G.; Pais de Barros, J.-P.; Laubriet, A.; Gambert, P.; Lizard, G.; Neél, D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ., 2004, 11, 897-905.
117. Vejux, A.; Guyot, S.; Montange, T.; Riedinger, J.-M.; Kahn, E.; Lizard, G. Phospholipidosis and down-regulation of the PI3K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J. Nutr. Biochem., 2008, Epub ahead of print.
118. Vejux, A.; Kahn, E.; Dumas, D.; Bessède, G.; Ménétrier, F.; Athias, A.; Riedinger, J.-M.; Frouin, F.; Stoltz, J.-F.; Ogier-Denis, E.; Todd-Pokropek, A.; Lizard, G. 7-Ketocholesterol favors lipid accumulation and colocalizes with Nile Red positive cytoplasmic structures formed during 7-ketocholesterol-induced apoptosis: Analysis by flow cytometry, FRET biphoton spectral imaging microscopy, and subcellular fractionation. Cytometry A, 2005, 64, 87-100.
119. Martinet, W.; De Bie, M.; Schrijvers, DM.; De Meyer, G.R.; Herman, A.G.; Kockx, M.M. 7-ketocholesterol induces protein ubiquitination, myelin figure formation, and light 3 chain processing in vascular smooth muscle cells. Atheroscler. Thromb. Vasc. Biol., 2004, 24, 2296-301.
120. Miguet-Alfonsi, C.; Prunet, C.; Monier, S.; Bessède, G.; Lemaire-Ewing, S.; Berthier, A.; Ménétrier, F.; Néel, D.; Gambert, P.; Lizard, G. Analysis of oxidative processes and of myelin figures formation before and after the loss of mitochondrial transmembrane potential during 7β-hydroxycholesterol and 7-ketocholesterol-induced apoptosis: Comparison with various pro-apoptotic chemicals. Biochem. Pharmacol., 2002, 64, 527-41.
121. Shao, D.; Segal, A.W.; Dekker, L.V. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett., 2003, 550, 101-6.
122. Vilhardt, F.; van Deurs, B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J., 2004, 23, 739-48.
123. Palladini, G.; Finardi, G.; Bellomo, G. Disruption of actin microfilament organization by cholesterol oxides in 73/73 endothelial cells. Exp. Cell Res., 1996, 223, 72-82.
124. Palladini, G.; Finardi, G.; Bellomo, G. Modifications of vimentin filament architecture and vimentin-nuclear interactions by cholesterol oxides in 73/73 endothelial cells. Exp. Cell Res., 1996, 223, 83-90.
125. Berthier A.; Lemaire-Ewing S.; Prunet, C.; Montange, T.; Vejux, A.; Pais de Barros, J.P.; Monier, S.; Gambert, P.; Lizard, G.; Néel, D. 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also anti-apoptotic calcium-dependent transduction pathways. FEBS J., 2005, 272, 3093-104.
126. Lemaire-Ewing, S.; Prunet, C.; Montange, T.; Vejux, A.; Berthier, A.; Bessède, G.; Corcos, L.; Gambert, P.; Néel, D.; Lizard, G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol., 2005, 21, 97-114.
127. Rimner, A.; Al Makdessi, S.; Sweidan, H.; Wischhusen, J.; Rabenstein, B.; Shatat, K.; Mayer, P.; Spyridopoulos, I. Relevance and mechanism of oxysterol stereospecifity in coronary artery disease. Free Radic. Biol. Med., 2005, 38, 535-34.
128. Hwang, P.L.; Matin, A. Interactions of sterols with antiestrogen-binding sites: Structural requirements for high-affinity binding. J. Lipid Res., 1989, 30, 239-45.
129. Blanco-Colio, L.M.; Villa, A.; Ortego, M.; Hérnandez-Presa, M.A.; Pascual, A.; Plaza, J.J.; Egido, J. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis, 2002, 161, 17-26.
130. Kaneko, R.; Tsuji, N.; Asanuma, K.; Tanabe, H.; Kobayashi, D.; Watanabe, N. Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer. J. Biol. Chem., 2007, 282, 19273-81.
131. Prunet, C.; Montange, T.; Véjux, A.; Laubriet, A.; Rohmer, J.F.; Riedinger, J.M.; Athias, A.; Lemaire-Ewing, S.; Néel, D.; Petit, J.M.; Steinmetz, E.; Brenot, R.; Gambert, P.; Lizard, G. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A., 2006, 69, 359-73.
132. Kraemer, R.; Pomerantz, K.B.; Joseph-Silverstein, J.; Hajjar, D.P. Induction of basic fibroblast growth factor mRNA and protein synthesis in smooth muscle cells by cholesteryl ester enrichment and 25-hydroxycholesterol. J. Biol. Chem., 1993, 268, 8040-5.
133. Rosklint T.; Ohlsson B.G.; Wilklund O.; Norén K.; Hultén, L.M. Oxysterols induce interleukin-1β production in human macrophages. Eur. J. Clin. Invest., 2002, 32, 35-42.
134. Lizard, G.; Lemaire, S.; Monier, S.; Gueldry, S.; Néel, D.; Gambert, P. Induction of apoptosis and of interleukin-1β secretion by 7β-hydroxycholesterol and 7-ketocholesterol: Partial inhibition by Bcl-2 overexpression. FEBS Lett., 1997, 419, 276-80.
135. Lemaire, S.; Lizard, G.; Monier, S.; Miguet, C.; Gueldry, S.; Volot, F.; Gambert, P.; Néel, D. Different patterns of IL-1β secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7α, 7β-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett., 1998, 440, 434-9.
136. Yudkin, J.S.; Kumari, M.; Humphries, S.E.; Mohamed-Ali, V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis, 2000, 148, 209-14.
137. Sung, S.C.; Kim, K.; Lee, K.A.; Choi, K.H.; Kim, S.M.; Son, Y.H.; Moon, Y.S.; Eo, S.K.; Rhim, B.Y. 7-Ketocholesterol upregulates interleukin-6 via mechanisms that are distinct from those of tumor necrosis factor-α, in vascular smooth muscle cells. J. Vasc. Res., 2008, 46, 36-44.
138. Ikeda, U.; Ito, T.; Shimada, K. Interleukin-6 and acute coronary syndrome. Clin. Cardiol., 2001, 24, 701-4.
139. Rydberg, E.K.; Salomonsson, L.; Hultén, L.M.; Norén, K.; Bondjers, G.; Wiklund, O.; Björnheden, T.; Ohlsson, B.G. Hypoxia increases 25-hydroxycholesterol-induced interleukin-8 protein secretion in human macrophages. Atherosclerosis, 2003, 170, 245-52.
140. Lemaire-Ewing, S.; Berthier, A.; Royer, M.C.; Logette, E.; Corcos, L.; Bouchot, A.; Monier, S.; Prunet, C.; Raveneau, M.; Rébé, C.; Desrumaux, C.; Lizard, G.; Néel, D. 7β-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: Oxysterols-induced IL-8 secretion is calcium-dependent. Cell. Biol. Toxicol. 2008, Epub ahead of print.
141. Erridge, C.; Webb, D.J.; Spickett, C.M. 25-Hydroxycholesterol, 7β-hydroxycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic. Res., 2007, 41, 260-6.
142. Bai, B.; Yamamoto, K.; Sato, H.; Sugiura, H; Tanaka, T. Combined effect of 25-hydroxycholesterol and IL-1β on IL-8 production in human colon carcinoma cell line (Caco-2). Inflammation, 2005, 29, 141-6.
143. Moreau, M.; Brocheriou, I.; Petit, L.; Ninio, E.; Chapman, M.J.; Rouis, M. Interleukin-8 mediates downregulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: relevance to stability of atherosclerotic plaque. Circulation, 1999, 99, 420-6.
144. Joffre, C.; Leclère, L.; Buteau, B.; Martine, L.; Cabaret, S.; Malvitte, L.; Acar, N.; Lizard, G.; Bron, A.; Creuzot-Garcher, C.; Bretillon, L. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr. Eye Res., 2007, 32, 271-80.
145. Landis, M.S.; Patel, H.V.; Capone, J.P. Oxysterol activators of liver X receptor and 9-cis-retinoic acid promote sequential steps in the synthesis and secretion of tumor necrosis factor-α from human monocytes. J. Biol. Chem., 2002, 277, 4713-21.
146. Feng, Y.; Schreiner, G.F.; Chakravarty, S.; Liu, D.Y.; Joly, A.H. Inhibition of the mitogen activated protein kinase, p38α, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading. Atherosclerosis, 2001, 158, 331-8.
147. Leonarduzzi, G.; Sevanian, A.; Sottero, B.; Arkan, M.C.; Biasi, F.; Chiarpotto, E.; Basaga, H.; Poli, G. Up-regulation of the fibrogenic cytokine TGF-β1 by oxysterols: A mechanistic link between cholesterol and atherosclerosis. FASEB J., 2001, 15, 1619-21.
148. Leonarduzzi, G.; Gamba, P.; Sottero, B.; Kadl, A.; Robbesyn, F.; Calogero, R.A.; Biasi, F.; Chiarpotto, E.; Leitinger, N.; Sevanian, A.; Poli, G. Oxysterol-induced up-regulation of MCP-1 expression and synthesis in macrophage cells. Free Radic. Biol. Med., 2005, 39, 1152-61.
149. Tamasawa, N.; Murakami, H.; Matsui, J.; Yamato, K.; JingZhi, G.; Imaizumi, T.; Fujimoto, K.; Yoshida, H.; Satoh, K.; Suda, T. An oxidized derivative of cholesterol increases the release of soluble vascular cell adhesion molecule-1 from human umbilical vein endothelial cells in culture. Biochim. Biophys. Acta, 2001, 1531, 178-87.
150. Naito, Y.; Shimozawa, M.; Manabe, H.; Nakabe, N.; Katada, K.; Kokura, S.; Yoshida, N.; Ichikawa, H.; Kon, T.; Yoshikawa, T. Azelnidipine, a new calcium channel blocker, inhibits endothelial inflammatory response by reducing intracellular levels of reactive oxygen species. Eur. J. Pharmacol., 2006, 546, 11-8.
151. Dulak, J.; Józkowicz, A.; Dichtl, W.; Alber, H.; Schwarzacher, S.P.; Pachinger, O.; Weidinger, F. Vascular endothelial growth factor: angiogenesis, atherogenesis or both? Atherosclerosis, 2001, 159, 325-32.
152. Dushkin, M.I.; Khoshchenko, O.M.; Kudinova, E.N.; Schwartz, Y.Sh. Effects of hydroxysterols and atorvastatin on lipopolysaccharide-induced secretion of tumor necrosis factor and interleukin-10 by mouse macrophages. Bull. Exp. Biol. Med., 2006, 141, 233-5.
153. Fuhrman, B.; Partoush, A.; Volkova, N.; Aviram, M. Ox-LDL induces monocyte-to-macrophage differentiation in vivo: Possible role for the macrophage colony stimulating factor receptor (MCSF-R). Atherosclerosis, 2008, 196, 598-607.
154. Steinberg, D.; Parthasarathy, S.; Carew, T.E.; Khoo, J. C.; Witztum, J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med., 1989, 320, 915-24.
155. Garcia-Cruset, S.; Carpenter, K.L.; Guardiola, F.; Mitchinson, M.J. Oxysterols in cap and core of human advanced atherosclerotic lesions. Free Radic. Res., 1999, 30, 341-50.
156. Myoishi, M.; Hao, H.; Minamino,T.; Watanabe, K.; Nishihira, K.; Hatakeyama, K.; Asada, Y.; Okada, K.-I.; Ishibashi-Ueda, H.; Gabbiani, G.; Bochaton-Piallat, M.-L.; Mochizuki, N.; Kitakaze, M. Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome. Circulation, 2007, 116, 1226-33.
157. Björkhem, I.; Meaney, S. Brain cholesterol: Long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 806-15.
158. Heverin, M.; Bogdanovic, N.; Lütjohann, D.; Bayer, T.; Pikuleva, I.; Bretillon, L.; Diczfalusy, U.; Winblad, B.; Björkhem, I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res., 2004, 45, 186-93.
159. Heverin, M.; Meaney, S.; Lütjohann, D.; Diczfalusy, U.; Wahren, J.; Björkhem, I. Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J. Lipid Res., 2005, 46, 1047-52.
160. Zhang, J; Akwa, Y.; el-Etr, M.; Baulieu, E.-E.; Sjövall, J. Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons. Biochem. J., 1997, 322, 175-84.
161. Björkhem, I. Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med., 2006, 260, 493-508.
162. Vaya, J.; Schipper, H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem., 2007, 102, 1727-37.
163. Wolozin, B. Cholesterol and the biology of Alzheimer's disease. Neuron, 2004, 41, 7-10.
164. Famer, D.; Meaney, S; Mousavi, M.; Nordberg, A.; Björkhem, I.; Crisby, M. Regulation of α- and β-secretase activity by oxysterols: Cerebrosterol stimulates processing of APP via the α-secretase pathway. Biochem. Biophys. Res. Commun., 2007, 359, 46-50.
165. Nelson, T.J.; Alkon, D.L. Oxidation of cholesterol by amyloid precursor protein and β-amyloid peptide. J. Biol. Chem., 2005, 280, 7377-87.
166. Fliesler, S.J.; Peachey, N.S.; Richards, M.J.; Nagel, B.A.; Vaughan, D.K. Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: Electrophysiologic, biochemical, and morphologic features. Arch. Ophthalmol., 2004, 122, 1190-200.
167. De Fabiani, E.; Caruso, D.; Cavalieri, M.; Galli Kienle, M.; Galli, G. Cholesta-5,7,9(11)-trien-3 β-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J. Lipid Res., 1996, 37, 2280-7.
168. Vaughan, D.K.; Peachey, N.S.; Richards, M.J.; Buchan, B.; Flieser, S.J. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Exp. Eye Res., 2006, 82, 496-504.
169. Torrini, M.; Marchese, C.; Vanzetti, M.; Marini, V.; Origine, P.; Garrè, C.; Mareni, C. Mutation analysis of oxisterol-binding-protein gene in patients with age-related macular degeneration. Genet. Test., 2007, 11, 421-6.
170. Haigh, W.G.; Lee, S.P. Identification of oxysterols in human bile and pigment gallstones. Gastroenterology, 2001, 121, 118-23.
171. Seo, D.W.; Choi, H.-S.; Lee, S.P.; Kuver, R. Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. Am. J. Physiol. Gastrointest. Liver, 2004, 287, G1247-56.
172. Ishii, K.; Adachi, J.; Tomita, M.; Kurosaka, M.; Ueno, Y. Oxysterols as indices of oxidative stress in man after paraquat ingestion. Free Radic. Res., 2002, 36, 163-8.
173. Adachi, J.; Ishii, K.; Tomita, M.; Fujita, T.; Nurhantari, Y.; Nagasaki, Y.; Ueno, Y. Consecutive administration of paraquat to rats induces enhanced cholesterol peroxidation and lung injury. Arch. Toxicol., 2003, 77, 353-7.
174. Adachi, J.; Kudo, R.; Asano, M.; Ueno, Y.; Hunter, R.; Rajendram, R.; Martin, C.; Preedy, V.R. Skeletal muscle and liver oxysterols during fasting and alcohol exposure. Metabolism, 2006, 55, 119-27.
175. Siems, W.; Quast, S.; Peter, D.; Augustin, W.; Carluccio, F.; Grune, T.; Sevanian, A.; Hampl, H.; Wiswedel, I. Oxysterols are increased in plasma of end-stage renal disease patients. Kidney Blood Press. Res., 2005, 28, 302-6.
176. Ariyoshi, K.; Adachi, J.; Asano, M.; Ueno, Y.; Rajendram, R.; Preedy, V.R. Effect of chronic ethanol feeding on oxysterols in rat liver. Free Radic.Res., 2002, 36, 661-6.
177. Fujita, T.; Adachi, J.; Ueno, Y.; Peters, T.J.; Preedy, V.R. Chronic ethanol feeding increases 7-hydroperoxycholesterol and oxysterols in rat skeletal muscle. Metabolism, 2002, 51, 737-42.
178. Nakagawa, K.; Adachi, J.; Wong, M.C.Y.; Ueno, Y. Protective effect of daidzein against acute ethanol-induced lipid peroxidation in rat jejunum. Kobe J. Med Sci., 2006, 52, 141-9.
179. Adachi, J.; Kudo, R.; Ueno, Y.; Hunter, R.; Rajendram, R.; Want, E.; Preedy, V.R. Heart 7-hydroperoxycholesterol and oxysterols are elevated in chronically ethanol-fed rats. J. Nutr., 2001, 131, 2916-20.
180. Yoshioka, N.; Adachi, J.; Ueno, Y.; Yoshida, K. Oxysterols increase in diabetic rats. Free Radic. Res., 2005, 39, 299-304.
181. Wolozin, B.; Kellman, W.; Ruosseau, P.; Celesia, G.G.; Siegel, G. Decreased prevalence of Alzheimer disease associated with 3- hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch. Neurol., 2000, 57, 1439-43.
182. Jick, H.; Zornberg, G.L.; Jick, S.S.; Seshadri, S.; Drachman, D.A. Statins and the risk of dementia. Lancet, 2000, 356, 1627-31.
183. Rockwood, K.; Kirkland, S.; Hogan, D.B.; MacKnight, C.; Merry, H.; Verreault, R.; Wolfson, C.; McDowell, I. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch. Neurol., 2002, 59, 223-7.
184. Björkhem, I.; Lütjohann, D.; Breuer, O.; Sakinis, A.; Wennmalm, A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem., 1997, 272, 30178-84.
185. Locatelli, S.; Lütjohann, D.; Schmidt, H.H.-J.; Otto, C.; Beisiegel, U.; von Bergmann, K. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: Evidence that simvastatin affects cholesterol metabolism in the human brain. Arch. Neurol., 2002, 59, 213-6.
186. Vega, G.L.; Weiner, M.F.; Lipton, A.M.; von Bergmann, K.; Lütjohann, D.; Moore, C.; Svetlik, D. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. Arch. Neurol., 2003, 60, 510-5.
187. Thelen, K.M.; Lütjohann, D.; Vesalainen, R.; Janatuinen, T.; Knuuti, J.; von Bergmann, K.; Lehtimaki, T.; Laaksonen R. Effect of pravastatin on plasma sterols and oxysterols in men. Eur. J. Clin. Pharmacol., 2006, 62, 9-14.
188. Guan, J.Z.; Murakami, H.; Yamato, K.; Tanabe, J.; Matsui, J.; Tamasawa, N.; Suda T. Effects of fluvastatin in type 2 diabetic patients with hyperlipidemia: Reduction in cholesterol oxidation products and VCAM-1. J. Atheroscler. Thromb., 2004, 11, 56-61.
189. Thelen, K.M.; Laaksonen, R.; Pälvä, H.; Lehtimaki, T.; Lütjohann, D. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. J. Clin. Pharmacol., 2006, 46, 812-6.
190. Arca, M.; Natoli, S.; Micheletta, F.; Riggi, S.; Di Angelantonio, E.; Montali, A.; Antonini, T.M.; Antonini, R.; Diczfalusy, U.; Iuliano, L. Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic. Biol. Med., 2007, 42, 698-705.
191. Ludwig, P.W.; Hunninghake, D.B.; Hoidal, J.R. Increased leucocyte oxidative metabolism in hyperlipoproteinaemia. Lancet, 1982, 2, 348-50.
192. Nissen, S.E.; Tuzcu, E.M.; Shoenhagen, P.; Brown, B.G.; Ganz, P.; Vogel, R.A.; Crowe, T.; Howard, G.; Cooper, C.J.; Brodie, B.; Grines, C.L.; DeMaria A.N. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA, 2004, 291, 1071-80.
193. Jukema, J.W.; Liem, A.-H.; Dunselman, P.H.; van der Sloot, J.A.; Lok, D.J.; Zwinderman, A.H. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: Results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. Curr. Med. Res. Opin., 2005, 21, 1865-74.
194. Winkler, K.; Ablethauser, C.B.; Gimpelewicz, C.; Bortolini, M.; Isaacsohn, J.L. Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials. Clin. Ther., 2007, 29, 1987-2000.
195. Tall, A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J. Intern. Med., 2008, 263, 256-73.
196. Miwa, S.; Watada, H.; Omura, C.; Takayanagi, N.; Nishiyama, K.; Tanaka, Y.; Onuma, T.; Kawamori, R. Anti-oxidative effect of fluvastatin in hyperlipidemic type 2 diabetic patients. Endocr. J., 2005, 52, 259-64.
197. Plosker, J.L.; Wagstaff, A.J. Fluvastatin: A review of its pharmacology and use in the management of hypercholesterolaemia. Drugs, 1996, 51, 433-59.
198. Suzumura, K.; Yasuhara, M.; Narita, H. Superoxide anion scavenging properties of fluvastatin and its metabolites. Chem. Pharm. Bull., 1999, 47, 1477-80.
199. Csallany, A.S.; Hee-Lee, J.; Shoeman, D.W. Protection of superoxide-induced cholesterol oxidation by antioxidants in protic conditions. Int. J. Food Sci. Nutr., 2002, 53, 403-9.
200. Belinky, P.; Aviram, M.; Fuhrman, B.; Rosenblat, M.; Vaya, J. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. Atherosclerosis, 1998, 137, 49-61.
201. Rosenblat, M.; Belinky, P.; Vaya, J.; Levy, R.; Hayek,T.; Coleman, R.; Merchav, S.; Aviram, M. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J. Biol. Chem., 1999, 274, 13799.
202. Valenzuela, A.; Sanhueza, J.; Nieto, S. Cholesterol oxidation: Health hazard and the role of antioxidants in prevention. Biol. Res., 2003, 36, 291-302.
203. Valenzuela, A.; Sanhueza, J.; Alonso, P.; Corbari, A.; Nieto, S. Inhibitory action of conventional food-grade natural antioxidants and of natural antioxidants of new development on the thermal-induced oxidation of cholesterol. Int. J. Food Sci. Nutr., 2004, 55, 155-62.
204. Wen, Y.; Leake, D.S. Low density lipoprotein undergoes oxidation within lysosomes in cells. Circ. Res., 2007, 100, 1337-43.
205. Menéndez-Carreño, M.; Ansorena, D.; Milagro, F.I.; Campión, J.; Martínez, J.A.; Astiasarán, I. Inhibition of serum cholesterol oxidation by dietary vitamin C and selenium intake in high fat fed rats. Lipids, 2008, 43, 383-90.
206. Naito, Y.; Shimozawa, M.; Manabe, H.; Kuroda, M.; Tomatsuri, N.; Uchiyama, K.; Takagi, T.; Yoshida, N.; Yoshikawa, T. Inhibitory effects of red wine extracts on endothelial-dependent adhesive interactions with monocytes induced by oxysterols. Biol. Res., 2004, 37, 231-8.
207. Naito, Y.; Shimozawa, M.; Kuroda, M.; Nakabe, N.; Manabe, H.; Katada, K.; Kokura, S.; Ichikawa, H.; Yoshida, N.; Noguchi, N.; Yoshikawa, T. Tocotrienols reduce 25-hydroxycholesterol-induced monocyte-endothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis, 2005, 180, 19-25.
208. Ryan, L.; O'Callaghan, Y.C.; O'Brien, N.M. Comparison of the apoptotic processes induced by the oxysterols 7β-hydroxycholesterol and cholesterol-5β,6β-epoxide. Cell Biol. Toxicol., 2004, 20, 313-23.
209. Ruiz, E.; Padilla, E.; Redondo, S.; Gordillo-Moscoso, A.; Tejerina, T. Kaempferol inhibits apoptosis in vascular smooth muscle induced by a component of oxidized LDL. Eur. J. Pharmacol., 2006, 529, 79-83.
210. Nakazawa, T.; Xui, N.; Hesong, Z.; Kinoshita, M.; Chiba, T.; Kaneko, E.; Yui, K.; Shimokado, K. Danshen inhibits oxysterol-induced endothelial cell apoptosis in vivo. J. Atheroscler. Thromb., 2005, 12, 132-7.
211. Huang, K.; Liu, H.; Chen, Z.; Xu, H. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. Atherosclerosis, 2002, 162, 137-44.
212. Tang, R.; Huang, K. Inhibiting effect of selenium on oxysterols-induced apoptosis of rat vascular smooth muscle cells. J. Inorg. Biochem., 2004, 98, 1678-85.
213. Tang, R.; Liu, H.; Wang, T.; Huang, K. Mechanisms of selenium inhibition of cell apoptosis induced by oxysterols in rat vascular smooth muscle cells. Arch. Biochem. Biophys., 2005, 441, 16-24.
214. Wu, Q.; Huang, K. Protective effect of ebselen on cytotoxicity induced by cholestane-3β,5α, 6β-triol in ECV-304 cells. Biochim. Biophys. Acta, 2006, 1761, 350-9.
215. Lordan, S.; O'Neill, C.; O'Brien, N.M. Effects of apigenin, lycopene and astaxanthin on 7β-hydroxycholesterol-induced apoptosis and Akt phosphorylation in U937 cells. Br. J. Nutr., 2008, 100, 287-96.
216. Luoma, P.V. Cytochrome P450-physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Ann. Med., 2007, 39, 359-70.
217. Langmann, T.; Liebisch, G.; Moehle, C.; Schifferer, R.; Dayoub, R.; Heiduczek, S.; Grandl, M.; Dada, A.; Schmitz, G. Gene expression profiling identifies retinoids as potent inducers of macrophage lipid efflux. Biochim. Biophys. Acta, 2005, 1740, 155-61.
218. Nagata, K.; Yamazoe, Y. Pharmacogenetics of sulfotransferase. Annu. Rev. Pharmacol. Toxicol., 2000, 40, 159-76.
219. Javitt, N.B.; Lee, Y.C.; Shimizu, C.; Fuda, H.; Strott, C.A. Cholesterol and hydroxycholesterol sulfotransferases: Identification, distinction from dehydroepiandrosterone sulfotransferase, and differential tissue expression. Endocrinology, 2001, 142, 2978-84.
220. Fuda, H.; Javitt, N.B.; Mitamura, K.; Ikegawa, S.; Strott, C.A. Oxysterols are substrates for cholesterol sulfotransferase. J. Lipid Res., 2007, 48, 1343-52.